IL84189A0 - Pharmaceutical compositions containing tumor necrosis factors and anti-inflammatory agents - Google Patents

Pharmaceutical compositions containing tumor necrosis factors and anti-inflammatory agents

Info

Publication number: IL84189A0
Authority: IL; Israel
Prior art keywords: inflammatory agents; malignant; tumor necrosis; combinations; necrosis factors
Prior art date: 1986-10-16

Application number

IL84189A

Other languages

English (en)

Original Assignee

Biogen Nv

Harvard College

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-10-16

Filing date

1987-10-16

Publication date

1988-03-31

1987-10-16 Application filed by Biogen Nv, Harvard College filed Critical Biogen Nv

1988-03-31 Publication of IL84189A0 publication Critical patent/IL84189A0/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Rheumatology (AREA)
Zoology (AREA)
Pain & Pain Management (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IL84189A 1986-10-16 1987-10-16 Pharmaceutical compositions containing tumor necrosis factors and anti-inflammatory agents IL84189A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US91985186A	1986-10-16	1986-10-16

Publications (1)

Publication Number	Publication Date
IL84189A0 true IL84189A0 (en)	1988-03-31

Family

ID=25442745

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL84189A IL84189A0 (en)	1986-10-16	1987-10-16	Pharmaceutical compositions containing tumor necrosis factors and anti-inflammatory agents

Country Status (7)

Country	Link
EP (1)	EP0287633B1 (xx)
JP (1)	JPH01500905A (xx)
AT (1)	ATE91237T1 (xx)
DE (1)	DE3786456T2 (xx)
IL (1)	IL84189A0 (xx)
WO (1)	WO1988002632A1 (xx)
ZA (1)	ZA877771B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5508031A (en) *	1986-11-21	1996-04-16	Cetus Oncology Corporation	Method for treating biological damage using a free-radial scavenger and interleukin-2
DE3816169A1 (de) *	1988-05-11	1989-11-23	Boehringer Ingelheim Kg	Verwendung und mittel zur verminderung der nebenwirkungen von tnf
US6042837A (en) *	1989-09-20	2000-03-28	Kalland; Terje	Methods of staphylococcal enterotoxin directed cell-mediated cytotoxicity (SDCC)
US5728388A (en) *	1989-10-03	1998-03-17	Terman; David S.	Method of cancer treatment
DE69133485T2 (de) *	1990-01-17	2006-06-22	Terman, David S., Pebble Beach	Verwendung von Staphylococcus Enterotoxin Homologe für Krebs-Therapie
GB9005856D0 (en) *	1990-03-15	1990-05-09	Geistlich Soehne Ag	Compositions
WO1992020325A1 (en) *	1991-05-14	1992-11-26	Endocon, Inc.	Engineering the local inflammatory response as a means of controlled release drug delivery
AU3641597A (en)	1996-06-21	1998-01-07	Advanced Research And Technology Institute, Inc.	Methods and compositions comprising r-ibuprofen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4677064A (en) *	1984-11-09	1987-06-30	Cetus Corporation	Human tumor necrosis factor
AU7397887A (en) *	1986-05-09	1987-12-01	Sloan-Kettering Institute For Cancer Research	Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment

1987
- 1987-10-14 JP JP62506436A patent/JPH01500905A/ja active Pending
- 1987-10-14 AT AT87907079T patent/ATE91237T1/de not_active IP Right Cessation
- 1987-10-14 EP EP87907079A patent/EP0287633B1/en not_active Expired - Lifetime
- 1987-10-14 DE DE87907079T patent/DE3786456T2/de not_active Expired - Fee Related
- 1987-10-14 WO PCT/US1987/002602 patent/WO1988002632A1/en active IP Right Grant
- 1987-10-15 ZA ZA877771A patent/ZA877771B/xx unknown
- 1987-10-16 IL IL84189A patent/IL84189A0/xx unknown

Also Published As

Publication number	Publication date
WO1988002632A1 (en)	1988-04-21
EP0287633B1 (en)	1993-07-07
JPH01500905A (ja)	1989-03-30
EP0287633A4 (en)	1989-02-23
ATE91237T1 (de)	1993-07-15
EP0287633A1 (en)	1988-10-26
DE3786456D1 (de)	1993-08-12
ZA877771B (en)	1988-09-28
DE3786456T2 (de)	1994-02-03

Similar Documents

Publication	Publication Date	Title
ES2172654T3 (es)	2002-10-01	Uso de nsaid para el tratamiento de carcinomas de celulas escamosas de la cavidad oral u orofaringe.
HUT38125A (en)	1986-04-28	Process for preparing lymphokines /cytotoxic factors/ and pharmaceutical compositions containing such active substance
GEP20022784B (en)	2002-09-25	Celecoxib Composition
IE862554L (en)	1987-03-27	Pharmaceutical compositions
UA39158C2 (uk)	2001-06-15	Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
IL103303A (en)	1997-06-10	Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
GR3005528T3 (xx)	1993-06-07
DE69426334D1 (de)	2000-12-28	Parenterales Busulfan zur Behandlung von malignen Krankheiten
IL84189A0 (en)	1988-03-31	Pharmaceutical compositions containing tumor necrosis factors and anti-inflammatory agents
AU563762B2 (en)	1987-07-23	S-adenosyl-l-methionine salts preparation
DK0452598T3 (da)	1994-01-17	Anvendelsen af et polypeptid med humant-inter-leukin-2-aktivitet til fremstilling af farmaceutiske præparater til behandling af primitiv pleuracancer
IL105475A (en)	1997-06-10	PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
CA2078544A1 (en)	1991-10-11	Method and compositions for treating injury
DE3263832D1 (en)	1985-07-04	Gallium chloride, an anti-cancer drug
ZA81927B (en)	1982-03-31	Phenylpiperazine derivatives of 1,3,4-oxadiazolyphenols their preparation and therapeutic agents containing these compounds
ES527353A0 (es)	1984-12-01	Procedimiento de preparacion de nuevos derivados de la nitrosourea
DE2966809D1 (en)	1984-04-19	3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
YU25202A (sh)	2004-12-31	Supstituisani piroli kao antiproliferativna sredstva za lečenje kancera
SE8402199L (sv)	1984-10-23	Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
ZA839196B (en)	1985-07-31	Analgesic combinations
EP0670165B1 (en)	2001-12-12	Use of seminal ribonuclease as antimetastatic compound
IT1265342B1 (it)	1996-11-22	Composizioni farmaceutiche a base di derivati della glicina
EP0342015A3 (en)	1990-10-10	Peptides, their use and pharmaceutical compositions containing them
Lin et al.	1986	THE CON A CONJUGATE OF BOWMAN-BIRK SOYBEAN TRYPSIN INHIBITOR IS AN ANTICARCINOGEN.
MX9707811A (es)	1998-01-31	Una composicion farmaceutica que contiene n-clorofenilcarbamatos, n-clorofeniltiocarbamatos y derivados de n-fosfonoglicina para inhibir el crecimiento de canceres y virus en mamiferos.